ATE23337T1 - Chromanverbindungen. - Google Patents

Chromanverbindungen.

Info

Publication number
ATE23337T1
ATE23337T1 AT83307599T AT83307599T ATE23337T1 AT E23337 T1 ATE23337 T1 AT E23337T1 AT 83307599 T AT83307599 T AT 83307599T AT 83307599 T AT83307599 T AT 83307599T AT E23337 T1 ATE23337 T1 AT E23337T1
Authority
AT
Austria
Prior art keywords
chroman
connections
compounds
formula
alpha2
Prior art date
Application number
AT83307599T
Other languages
English (en)
Inventor
Cyrus John Ohnmacht Jr
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici America Inc filed Critical Ici America Inc
Application granted granted Critical
Publication of ATE23337T1 publication Critical patent/ATE23337T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT83307599T 1982-12-23 1983-12-14 Chromanverbindungen. ATE23337T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8236602 1982-12-23
EP83307599A EP0115142B1 (de) 1982-12-23 1983-12-14 Chromanverbindungen

Publications (1)

Publication Number Publication Date
ATE23337T1 true ATE23337T1 (de) 1986-11-15

Family

ID=10535191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83307599T ATE23337T1 (de) 1982-12-23 1983-12-14 Chromanverbindungen.

Country Status (7)

Country Link
EP (1) EP0115142B1 (de)
JP (1) JPS59130286A (de)
AT (1) ATE23337T1 (de)
CA (1) CA1219267A (de)
DE (1) DE3367391D1 (de)
ES (1) ES528365A0 (de)
GR (1) GR79710B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1216119A (en) * 1984-05-16 1987-01-06 Mitsui Chemicals, Incorporated Process for producing stretched article of ultrahigh- molecular weight polyethylene
GB8805628D0 (en) * 1988-03-09 1988-04-07 Erba Farmitalia Hypolipidaemic imidazol-2-yl-derivatives of bicyclic compounds & process for their preparation
FR2639227A1 (fr) * 1988-11-23 1990-05-25 Sanofi Sa Utilisation de derives du chromane pour le traitement des etats depressifs
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd ６―フルオロクロモン―２―カルボン酸及びその製造法
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2787451B1 (fr) * 1998-12-18 2001-01-26 Adir Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2000073269A2 (en) * 1999-06-02 2000-12-07 Regents Of The University Of Minnesota Nicotine receptor ligands
JP2002226473A (ja) * 2000-08-29 2002-08-14 Kuraray Co Ltd クロマンカルボン酸の製造方法
CZ20013076A3 (cs) * 2000-08-29 2002-04-17 Kuraray Co., Ltd. Způsob výroby chromankarboxylové kyseliny
DE10348257A1 (de) * 2003-10-16 2005-05-25 Merck Patent Gmbh Verfahren zur Herstellung von enantiomereneinen in 2-Position substituierten Chromanderivaten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA960223A (en) * 1970-02-05 1974-12-31 Mervyn E. Peel Tetrazolyl chromones
DE2021899A1 (de) * 1970-05-05 1971-11-25 Basf Ag Sulfonsaeuregruppenhaltige Farbstoffe und deren Salze
ZA739471B (en) * 1972-12-22 1974-08-28 Hoffmann La Roche Chromane derivatives
JPS5529110B2 (de) * 1972-12-25 1980-08-01
DE2413849A1 (de) * 1974-03-22 1975-10-02 Bayer Ag Neue ungesaettigte chromanderivate
FR2436785A1 (fr) * 1978-09-25 1980-04-18 Warner Lambert Co 3-(1h-tetrazol-5-yl) chromones et leur utilisation therapeutique
DE2909601A1 (de) * 1979-03-12 1980-09-25 Basf Ag Verfahren zur herstellung von chromanderivaten
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use

Also Published As

Publication number Publication date
JPS59130286A (ja) 1984-07-26
GR79710B (de) 1984-10-31
ES8601190A1 (es) 1985-11-01
DE3367391D1 (en) 1986-12-11
ES528365A0 (es) 1985-11-01
EP0115142B1 (de) 1986-11-05
CA1219267A (en) 1987-03-17
EP0115142A1 (de) 1984-08-08

Similar Documents

Publication Publication Date Title
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
NO882588L (no) Fremgangsmaate ved fremstilling av substituerte inololinonderivater.
ATE23337T1 (de) Chromanverbindungen.
EP0411912A3 (en) Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
DE3068379D1 (en) Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
DE3477380D1 (en) Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
ES2044900T3 (es) Un proceso para la preparacion de un derivado de antraciclina.
SE8803765L (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
BG47034A3 (en) Method for preparing of 7- /meta- substituted/- phenylglycine- 1- carba- 1- dithiacephalosporines
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat
WO1987007609A1 (en) 1,1,2-triaryl-1-butene derivatives
DE69907671D1 (en) Hydroxyphenylsulfanylbenzoesäure- und -arylessigsäure-derivate
EP0309262A3 (de) Salicylate, ihre Salze, diese enthaltende pharmazeutische Kompositionen und ihr Herstellungsverfahren
ES479233A1 (es) Procedimiento para la obtencion de derivados de antraquinona.
PH22441A (en) Quinate salts of the antimaterial compound mefloquine
SE8600411D0 (sv) Isokinolinderivat, deras framstellning och anvendning

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee